|
C6ORF182 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.420000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.254290E-02 |
| Normal-vs-Stage2 |
5.835600E-01 |
| Normal-vs-Stage3 |
7.346000E-01 |
| Normal-vs-Stage4 |
9.907800E-01 |
| Stage1-vs-Stage2 |
4.300800E-01 |
| Stage1-vs-Stage3 |
7.431800E-02 |
| Stage1-vs-Stage4 |
3.491400E-01 |
| Stage2-vs-Stage3 |
5.185200E-01 |
| Stage2-vs-Stage4 |
7.471000E-01 |
| Stage3-vs-Stage4 |
8.370200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.333800E-02 |
| Normal-vs-AfricanAmerican |
4.166400E-01 |
| Normal-vs-Asian |
2.569400E-01 |
| Caucasian-vs-AfricanAmerican |
5.994800E-01 |
| Caucasian-vs-Asian |
9.500800E-01 |
| AfricanAmerican-vs-Asian |
8.209600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.684200E-03 |
| Normal-vs-Female |
3.842200E-01 |
| Male-vs-Female |
2.815800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.846200E-01 |
| Normal-vs-Extreme_Weight |
9.560300E-04 |
| Normal-vs-Obese |
2.685000E-01 |
| Normal-vs-Extreme_Obese |
8.338200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.250380E-01 |
| Normal_Weight-vs-Obese |
8.565600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.505800E-01 |
| Extreme_Weight-vs-Obese |
4.835500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.480100E-02 |
| Obese-vs-Extreme_Obese |
4.385200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.440400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.918000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.339700E-03 |
| Normal-vs-Age(81-100Yrs) |
4.140200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.710600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.850400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.202000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.646120E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.416000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.340600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.584400E-02 |
| Normal-VS-Type2 PRCC |
2.541200E-01 |
| Normal-VS-KIRP CIMP |
6.900800E-01 |
| Normal-VS-Unclassified PRCC |
3.442000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.033800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.573830E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.655400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.272400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.821600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.045200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.659600E-02 |
| Normal-vs-N1 |
3.717000E-01 |
| Normal-vs-N2 |
2.660600E-01 |
| N0-vs-N1 |
2.921800E-02 |
| N0-vs-N2 |
4.278800E-01 |
| N1-vs-N2 |
1.484040E-01 |
|
|
